Trial of Regulatory T-cells Plus Low-Dose Interleukin-2 for Steroid-Refractory Chronic Graft-versus-Host-Disease
Clinical trial NCT01937468 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT01937468
- Sponsor
- Dana-Farber Cancer Institute
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-11-01
- Primary completion
- 2017-08-01
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.